Forte Biosciences, Inc. (FBRX)
Largest Insider Buys in Sector
FBRX Stock Price History Chart
FBRX Stock Performance
About Forte Biosciences, Inc.
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
Insider Activity of Forte Biosciences, Inc.
Over the last 12 months, insiders at Forte Biosciences, Inc. have bought $124,998 and sold $0 worth of Forte Biosciences, Inc. stock.
On average, over the past 5 years, insiders at Forte Biosciences, Inc. have bought $169,671 and sold $4.45M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Riley Antony A (CHIEF FINANCIAL OFFICER) — $249,995.
The last purchase of 22,514 shares for transaction amount of $124,998 was made by Riley Antony A (CHIEF FINANCIAL OFFICER) on 2024‑11‑21.
List of Insider Buy and Sell Transactions, Forte Biosciences, Inc.
| 2024-11-21 | CHIEF FINANCIAL OFFICER | 22,514 0.5477% | $5.55 | $124,998 | +45.56% | |||
| 2023-12-18 | See Remarks | 10,000 0.0286% | $0.75 | $7,525 | -14.80% | |||
| 2023-12-14 | See Remarks | 10,000 0.0287% | $0.72 | $7,200 | -11.70% | |||
| 2023-12-13 | See Remarks | 10,520 0.0284% | $0.70 | $7,351 | -12.86% | |||
| 2023-12-12 | See Remarks | 4,776 0.013% | $0.65 | $3,088 | -6.84% | |||
| 2023-12-11 | See Remarks | 25,000 0.0719% | $0.65 | $16,188 | 0.00% | |||
| 2023-12-08 | See Remarks | 15,000 0.0406% | $0.62 | $9,300 | 0.00% | |||
| 2023-12-07 | See Remarks | 36,203 0.0971% | $0.58 | $21,168 | +5.17% | |||
| 2023-11-22 | See Remarks | 400 0.0011% | $0.43 | $172 | +37.86% | |||
| 2023-11-20 | See Remarks | 6,966 0.0175% | $0.44 | $3,048 | +21.00% | |||
| 2022-12-16 | See Remarks | 44,024 0.2759% | $1.07 | $47,000 | +2.04% | |||
| 2022-12-15 | See Remarks | 55,976 0.3253% | $1.03 | $57,672 | -1.96% | |||
| 2021-09-07 | Sale | See Remarks | 1M 7.2851% | $4.35 | $4.35M | -65.57% | ||
| 2021-09-07 | Sale | Chief Financial Officer | 25,000 0.1778% | $4.24 | $106,105 | -65.57% | ||
| 2020-06-29 | Chief Financial Officer | 2,000 0.0544% | $14.11 | $28,220 | +145.46% | |||
| 2020-06-26 | Chief Financial Officer | 4,700 0.1262% | $14.52 | $68,225 | +135.52% | |||
| 2020-06-25 | See Remarks | 7,000 0.1998% | $14.48 | $101,356 | +150.76% | |||
| 2020-04-14 | 10 percent owner | 74,301 0.1242% | $1.19 | $88,418 | +54.56% | |||
| 2020-03-02 | 10 percent owner | 65,149 0.0283% | $1.35 | $87,756 | -0.52% | |||
| 2019-05-30 | director | 43,000 0.0242% | $4.66 | $200,315 | -77.34% |
Insider Historical Profitability
| Riley Antony A | CHIEF FINANCIAL OFFICER | 30776 2.1052% | $18.55 | 3 | 1 | +140.49% |
| Oliveira Steven Michael | 10 percent owner | 2873450 196.5518% | $18.55 | 2 | 0 | +27.02% |
| Wagner Paul A. | See Remarks | 1823236 124.7143% | $18.55 | 12 | 1 | +50.28% |
| Hasnain Faheem | director | 245857 16.8173% | $18.55 | 2 | 0 | |
| FOLETTA MARK G | EVP & Chief Financial Officer | 15042 1.0289% | $18.55 | 2 | 0 |
Institutional Investor Ownership
| Tybourne Capital Management HK Ltd | $2.52M | 9.95 | 3.62M | 0% | +$0 | 0.43 | |
| Perceptive Advisors | $2.27M | 8.96 | 3.27M | 0% | +$0 | <0.01 | |
| Bvf Inc Il | $2.09M | 8.18 | 2.98M | 0% | +$0 | 0.02 | |
| Alger | $1.28M | 5.05 | 1.84M | 0% | +$0 | 0.01 | |
| Farallon Capital | $1.27M | 4.97 | 1.81M | 0% | +$0 | 0.01 |